Penn-developed AI tools and datasets help tailor treatments for kidney patients
Penn Medicine and Wharton researchers have partnered to create CellSpectra and SISKA, offering clues to better treatments for kidney disease and beyond.
2 min. read
Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School of Medicine and the Wharton School can analyze kidney disease at the cellular level to match the most effective treatments and speed up solutions. This research is published in Nature Genetics.
“Kidney diseases are not all the same, but the use of AI helped us identify and catalog 70 distinct kinds of kidney cells that appear across human and animal samples. This improves the reliability of research and can lead to potential treatments,” says Katalin Susztak, a professor of nephrology and genetics and director of the Penn/CHOP Kidney Innovation Center.
The Penn team tackled a major challenge in single-cell RNA sequencing, a cutting-edge technique that examines the genetic activity of individual cells. The solution includes SISKA 1.0 Atlas: A massive dataset built from over 1 million cells across 140 human, mouse, and rat kidney samples. In combination with a new statistical method that examines gene programs—sets of co-regulated genes representing biological pathways—rather than individual genes, it was easier to spot disease-related problems in a person’s cells.
“We built CellSpectra to do what current methods cannot: analyze one patient’s sample at a time, and interpret it in the context of species, disease, and therapy,” says Nancy Zhang, the Ge Li and Ning Zhao Professor of Statistics at the Wharton School.
The Susztak team has also created the first comprehensive catalog of kidney proteins, offering a new lens on how protein abundance, not just gene expression, contributes to disease. This work, published in Nature Medicine, finds that protein levels in kidney cells often don’t match gene activity (a mismatch called discordance), showing that studying genes alone isn’t enough to understand how diseases develop.
The Polyhedral Structures Laboratory is housed at the Pennovation Center and brings together designers, engineers, and computer scientists to reimagine the built world. Using graphic statics, a method where forces are mapped as lines, they design forms that balance compression and tension. These result in structures that use far fewer materials while remaining strong and efficient.
From ancient tombs and tiny robots to personalized gene editing and AI weather models, Penn’s 2025 research portfolio showed how curiosity—paired with collaboration—moves knowledge into impact and stretches across disciplines and continents.
Centering joy in AI development and implementation
PIK Professor Desmond Upton Patton—of Annenberg and SP2—and collaborators introduce a joy-informed framework designed to initiate conversations among engineers, designers, and researchers.
Reflecting on Jane Austen, 250 years after her birth
English professors Michael Gamer and Barri Joyce Gold have been teaching courses specifically dedicated to Jane Austen for years. They spoke with Penn Today about their approach to teaching her novels, how they challenge common readings and myths, and what makes Austen’s work so enduring—and adaptable to the screen—more than two centuries later.
Electronic medical records help save lives of HIV patients
Wharton’s Leandro “Leo” Pongeluppe and colleagues found that HIV clinics in Malawi that switched from paper to electronic medical records saw an estimated 28% reduction in deaths in five years.
